Galenika a.d.

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bender the Bot (talk | contribs) at 05:12, 30 October 2016 (→‎top: http→https for Google Books and Google News using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Galenika a.d.
Native name
Галеника а.д.
Company typePublic limited company
BELEX: FITO
IndustryPharmaceuticals
FoundedBelgrade, Serbia (April 30, 1991 (1991-04-30))
First founded 1945
Headquarters,
Key people
Živomir Novaković (general director)
ProductsGeneric drugs, over-the-counter drugs, medical devices
RevenueDecrease 40.42 million (2013)[1]
Increase -€43.78 million (2013)[1]
Total assetsIncrease €223.90 million (2013)[1]
Total equitySteady €0 (2013)[1]
OwnerIndividuals (52.63%)
Agromarket (16.64%)
Others
Number of employees
2,236[1]
Websitewww.galenika.rs

Galenika a.d. is a Serbian pharmaceutical company based in Zemun, Belgrade, controlling one-third of the pharmaceutical market share in the country. Founded in 1945, Galenika is a major pharmaceutical drug-maker in the Balkans with exports to Europe, Africa and Asia.

Still a state-owned company, Galenika is gradually moving towards a privatized model. The Government of Serbia announced its intent to privatize Galenika sometime in 2013.[2]

As of 2006, Galenika remains a leader in research and development as the only pharmaceutical company in Serbia with an institute registered with the Ministry of Science and Environmental Protection.[3]

Logos

From 1945, for this company, there are four different logos. The first logo of company is used from 1945 to 1992, the second logo is used from 1992 to 1998 (which has been marked as ICN Galenika), the third logo is used from 1998 to 2002, and the fourth and current logo is in use from 2002.

Market and financial data

According to its most recent annual financial report submitted to Serbian Business Registers Agency (SBRA), the company has approximately 2,200 employees and it posted an annual loss of RSD 5,018,790,000 (approximately 43.78 million at the time) for the calendar year of 2013.[1] As of 29 May 2015, Galenika has a market capitalization of 48.17 million.[4]

References

  1. ^ a b c d e f Основни подаци из консолидованог финансијског извештаја за 2013. годину. Agencija za privredne registre Srbije (in Serbian). Retrieved 17 June 2014.
  2. ^ "Serbia to Start Sale of Galenika Drugmaker in Early 2013". Bloomberg. 13 December 2012. Retrieved 9 April 2013.
  3. ^ Doing Business with Serbia By Marat Terterov, Consultant Editor, Marat Terterov, Inc NetLibrary; Published by GMB Publishing Ltd, 2006; ISBN 1-905050-68-2, ISBN 978-1-905050-68-0.
  4. ^ "FITO - Galenika Fitofarmacija a.d. , Zemun - 29.05.2015". belex.rs. Retrieved 30 May 2015.

External links